A Study of Crisaborole ointment 2% in children aged 3-24 months with mild to moderate atopic dermatitis - Trial 2019-002836-10
Access comprehensive clinical trial information for 2019-002836-10 through Pure Global AI's free database. This phase not specified trial is sponsored by Pfizer Inc. and is currently status unknown. The study focuses on Atopic Dermatitis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Pfizer Inc.
Pfizer Inc
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Incidence of treatment emergent AEs (including application site reactions), SAEs, and clinically significant changes in height, weight, vital signs, ECG and clinical laboratory parameters
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2019-002836-10
Non-Device Trial